Financings for June 9, 2025 June 9, 2025 Med-tech firms raising money in public or private financings, including: Nanalysis, Nuwellis, Venus Concept.Read More
In the clinic for June 9, 2025 June 9, 2025 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Guardant Health.Read More
Other news to note for June 9, 2025 June 9, 2025 Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Medinol, Microtech.Read More
Med-tech gainers and losers for June 2-6, 2025 June 9, 2025 The top 10 med-tech stock gainers and losers for the week.Read More
Regulatory actions for June 9, 2025 June 9, 2025 Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Arvinas, Astrazeneca, Hemispherian, OS Therapies, Pfizer.Read More
Other news to note for June 9, 2025 June 9, 2025 Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Fabre-Kramer, Obi, Pharmadrug, Tegmine.Read More
In the clinic for June 9, 2025 June 9, 2025 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apellis, Otsuka, Sobi, Valneva.Read More
Financings for June 9, 2025 June 9, 2025 Biopharmas raising money in public or private financings, including: Aytu, Kelun.Read More
Appointments and advancements for June 9, 2025 June 9, 2025 New hires and promotions in the biopharma industry, including: Candel, Celldex, Denovo.Read More
Biggest gainers and losers for June 2-6, 2025 June 9, 2025 The top 10 biopharma stock gainers and losers for the week.Read More